Health Care & Life Sciences » Pharmaceuticals | Shionogi & Co. Ltd.

Shionogi & Co. Ltd. | Mutual Funds

Mutual Funds that own Shionogi & Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Health Care Fund
11,193,954
3.45%
-2,021,700
1.3%
06/30/2018
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
2.91%
128,000
1.06%
07/31/2018
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
1.48%
2,000
1.05%
08/20/2018
Government Pension Fund - Global (The)
4,727,950
1.46%
698,599
0.03%
12/31/2017
Nomura Asset TOPIX ETF Fund (1306)
4,449,300
1.37%
70,500
0.36%
07/31/2018
Daiwa Asset NIKKEI 225 ETF (1320)
4,228,000
1.3%
-16,000
1.05%
07/31/2018
Vanguard Total International Stock Index Fund
4,006,448
1.24%
37,300
0.07%
07/31/2018
2,343,500
0.72%
-496,902
4.59%
10/31/2016
Mitsubishi UFJ MAXIS Nikkei 225 ETF (1346)
2,294,000
0.71%
46,000
1.04%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
2,183,800
0.67%
50,200
0.37%
07/31/2018

About Shionogi & Co.

View Profile
Address
3-1-8 Dosho-machi
Osaka Osaka 541
Japan
Employees -
Website http://www.shionogi.co.jp
Updated 07/08/2019
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.